These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21505879)

  • 21. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
    Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
    BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
    Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
    J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?
    Augestad LA; Rand K; Luo N; Barra M
    Value Health; 2020 Apr; 23(4):487-494. PubMed ID: 32327166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valuing health states: is the MACBETH approach useful for valuing EQ-5D-3L health states?
    Oliveira MD; Agostinho A; Ferreira L; Nicola P; Bana E Costa C
    Health Qual Life Outcomes; 2018 Dec; 16(1):235. PubMed ID: 30563525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study.
    Ratcliffe J; Chen G; Stevens K; Bradley S; Couzner L; Brazier J; Sawyer M; Roberts R; Huynh E; Flynn T
    Appl Health Econ Health Policy; 2015 Oct; 13(5):485-92. PubMed ID: 26135244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
    Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises.
    van Nooten FE; Houghton K; van Exel J; van Agthoven M; Brouwer WBF; Stull DE
    Value Health; 2017 Dec; 20(10):1403-1410. PubMed ID: 29241900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.
    Buitinga L; Braakman-Jansen LM; Taal E; van de Laar MA
    BMC Musculoskelet Disord; 2012 Jun; 13():112. PubMed ID: 22730908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method.
    Arnesen T; Trommald M
    J Health Serv Res Policy; 2004 Jan; 9(1):43-50. PubMed ID: 15006240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China.
    Xie S; Wu J; He X; Chen G; Brazier JE
    Value Health; 2020 Oct; 23(10):1391-1399. PubMed ID: 33032784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is it going to be, TTO or SG? A direct test of the validity of health state valuation.
    Lipman SA; Brouwer WBF; Attema AE
    Health Econ; 2020 Nov; 29(11):1475-1481. PubMed ID: 32744408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do the 15D scores and time trade-off (TTO) values of hospital patients' own health agree?
    Honkalampi T; Sintonen H
    Int J Technol Assess Health Care; 2010 Jan; 26(1):117-23. PubMed ID: 20059789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eliciting a value set for the Swedish Capability-Adjusted Life Years instrument (CALY-SWE).
    Meili KW; Mulhern B; Ssegonja R; Norström F; Feldman I; Månsdotter A; Hjelte J; Lindholm L
    Qual Life Res; 2024 Jan; 33(1):59-72. PubMed ID: 37695477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.